BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33111215)

  • 1. Systematic Review: Puberty suppression with GnRH analogues in adolescents with gender incongruity.
    Ramos GGF; Mengai ACS; Daltro CAT; Cutrim PT; Zlotnik E; Beck APA
    J Endocrinol Invest; 2021 Jun; 44(6):1151-1158. PubMed ID: 33111215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone Development in Transgender Adolescents Treated With GnRH Analogues and Subsequent Gender-Affirming Hormones.
    Schagen SEE; Wouters FM; Cohen-Kettenis PT; Gooren LJ; Hannema SE
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4252-63. PubMed ID: 32909025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Children and adolescents in the Amsterdam Cohort of Gender Dysphoria: trends in diagnostic- and treatment trajectories during the first 20 years of the Dutch Protocol.
    van der Loos MATC; Klink DT; Hannema SE; Bruinsma S; Steensma TD; Kreukels BPC; Cohen-Kettenis PT; de Vries ALC; den Heijer M; Wiepjes CM
    J Sex Med; 2023 Feb; 20(3):398-409. PubMed ID: 36763938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Back to the Future: Is GnRHa Treatment in Transgender and Gender Diverse Adolescents Only an Extended Evaluation Phase?
    Fisher AD; Ristori J; Romani A; Cassioli E; Mazzoli F; Cocchetti C; Pierdominici M; Marconi M; Ricca V; Maggi M; Vignozzi L; Castellini G
    J Clin Endocrinol Metab; 2024 May; 109(6):1565-1579. PubMed ID: 38099569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urological and Gynaecological Considerations for the Use of Gonadotropin-releasing Hormone Analogues in Transgender and Nonbinary Adolescents: A Narrative Review.
    Lee WG; Butler G; Carmichael P; Rashid T; Yasmin E; Morley R; Barrett J; Christopher N; Sangster P
    Eur Urol Focus; 2023 Jan; 9(1):35-41. PubMed ID: 36396559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Puberty suppression and executive functioning: An fMRI-study in adolescents with gender dysphoria.
    Staphorsius AS; Kreukels BP; Cohen-Kettenis PT; Veltman DJ; Burke SM; Schagen SE; Wouters FM; Delemarre-van de Waal HA; Bakker J
    Psychoneuroendocrinology; 2015 Jun; 56():190-9. PubMed ID: 25837854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.
    Hembree WC; Cohen-Kettenis PT; Gooren L; Hannema SE; Meyer WJ; Murad MH; Rosenthal SM; Safer JD; Tangpricha V; T'Sjoen GG
    J Clin Endocrinol Metab; 2017 Nov; 102(11):3869-3903. PubMed ID: 28945902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trajectories of Adolescents Treated with Gonadotropin-Releasing Hormone Analogues for Gender Dysphoria.
    Brik T; Vrouenraets LJJJ; de Vries MC; Hannema SE
    Arch Sex Behav; 2020 Oct; 49(7):2611-2618. PubMed ID: 32152785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Adrenal Androgens During Puberty Suppression and Gender-Affirming Hormone Treatment in Adolescents With Gender Dysphoria.
    Schagen SEE; Lustenhouwer P; Cohen-Kettenis PT; Delemarre-van de Waal HA; Hannema SE
    J Sex Med; 2018 Sep; 15(9):1357-1363. PubMed ID: 30224022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Puberty Assessment and Consideration of Gonadotropin-Releasing Hormone Agonists in Transgender and Gender-Diverse Youth.
    Lee JY
    Pediatr Ann; 2023 Dec; 52(12):e462-e466. PubMed ID: 38049185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Hip Bone Geometry During Gender-Affirming Hormone Therapy in Transgender Adolescents Resembles That of the Experienced Gender When Pubertal Suspension Is Started in Early Puberty.
    van der Loos MA; Hellinga I; Vlot MC; Klink DT; den Heijer M; Wiepjes CM
    J Bone Miner Res; 2021 May; 36(5):931-941. PubMed ID: 33507568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure dynamics after pubertal suppression with gonadotropin-releasing hormone analogs followed by estradiol treatment in transgender female adolescents: a pilot study.
    Perl L; Elkon-Tamir E; Segev-Becker A; Israeli G; Brener A; Oren A
    J Pediatr Endocrinol Metab; 2021 Jun; 34(6):741-745. PubMed ID: 33823098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood Pressure Dynamics After Pubertal Suppression with Gonadotropin-Releasing Hormone Analogs Followed by Testosterone Treatment in Transgender Male Adolescents: A Pilot Study.
    Perl L; Segev-Becker A; Israeli G; Elkon-Tamir E; Oren A
    LGBT Health; 2020; 7(6):340-344. PubMed ID: 32735503
    [No Abstract]   [Full Text] [Related]  

  • 14. Psychological Support, Puberty Suppression, and Psychosocial Functioning in Adolescents with Gender Dysphoria.
    Costa R; Dunsford M; Skagerberg E; Holt V; Carmichael P; Colizzi M
    J Sex Med; 2015 Nov; 12(11):2206-14. PubMed ID: 26556015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuation of gender-affirming hormones in transgender people starting puberty suppression in adolescence: a cohort study in the Netherlands.
    van der Loos MATC; Hannema SE; Klink DT; den Heijer M; Wiepjes CM
    Lancet Child Adolesc Health; 2022 Dec; 6(12):869-875. PubMed ID: 36273487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term outcomes of pubertal suppression in a selected cohort of 12 to 15 year old young people with persistent gender dysphoria in the UK.
    Carmichael P; Butler G; Masic U; Cole TJ; De Stavola BL; Davidson S; Skageberg EM; Khadr S; Viner RM
    PLoS One; 2021; 16(2):e0243894. PubMed ID: 33529227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Puberty suppression in adolescents with gender identity disorder: a prospective follow-up study.
    de Vries AL; Steensma TD; Doreleijers TA; Cohen-Kettenis PT
    J Sex Med; 2011 Aug; 8(8):2276-83. PubMed ID: 20646177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral and neurobiological effects of GnRH agonist treatment in mice-potential implications for puberty suppression in transgender individuals.
    Anacker C; Sydnor E; Chen BK; LaGamma CC; McGowan JC; Mastrodonato A; Hunsberger HC; Shores R; Dixon RS; McEwen BS; Byne W; Meyer-Bahlburg HFL; Bockting W; Ehrhardt AA; Denny CA
    Neuropsychopharmacology; 2021 Apr; 46(5):882-890. PubMed ID: 32919399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Puberty Suppression for Adolescents with Gender Dysphoria A Japanese Perspective].
    Matsumoto Y
    Seishin Shinkeigaku Zasshi; 2017; 119(1):42-51. PubMed ID: 30629867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transition memories: experiences of transĀ adult women with hormone therapy and their beliefs on the usage of hormone blockers to suppress puberty.
    Giovanardi G; Morales P; Mirabella M; Fortunato A; Chianura L; Speranza AM; Lingiardi V
    J Endocrinol Invest; 2019 Oct; 42(10):1231-1240. PubMed ID: 30953318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.